Actively Recruiting
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Led by Ju Qiu · Updated on 2024-06-24
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
J
Ju Qiu
Lead Sponsor
M
Ministry of Education, China
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying frailty screening tools in breast cancer patients aged 50 and older. They aim to compare the effectiveness of different frailty scales, including the Physical Frailty Phenotype, FRAIL Scale, Tilburg Frailty Index, and Geriatric-8, in predicting adverse health outcomes such as falls, unplanned hospitalizations, disability, and depression. This observational study explores which screening methods are most suitable for breast cancer patients in the researcher’s country. Participants will undergo basic inquiries and physical measurements only; no interventions or treatments are administered as part of the study. The study focuses on assessing frailty through various screening scales and does not involve any experimental therapies or medications. The goal is to select the best frailty screening tool for future clinical use among breast cancer patients. During the study, researchers will monitor participants from August 2023 through December 2025. They will track outcomes including falls, hospitalization rates, disability levels, and signs of depression. Participants must be able to walk independently or with walking aids. The study involves regular assessments but does not include treatments or interventions. It provides valuable information to improve frailty screening in this patient group over a period of more than two years.
CONDITIONS
Brief Title
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of breast cancer
- Age 50 years or older
- Treatment plan discussed by medical team includes surgery and chemotherapy
- Can walk independently or with walking aids
You will not qualify if you...
- Communication disorders
- Mental disorders that prevent normal cooperation
- Presence of other malignant tumours
- Terminal stage of disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From August 2023 to December 2025
Participants are observed through basic inquiries and measurements to assess frailty and predict adverse health outcomes.
Periodic assessments during the study period
Trial Site Locations
Total: 1 location
1
Ju Qiu
Chongqing, China
Actively Recruiting
Research Team
J
ju qiu, Bachelor.
L
lin zeng
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here